Disease Classification
|
|
|
|
|
(Yan et al., 2018) |
Conditional GAN |
ADNI |
MRI, PET |
Amyloid PET generation and MCI prediction |
(Liu et al., 2020) |
GAN |
ADNI |
MRI, PET |
MCI conversion prediction |
(Mirakhorli et al., 2020) |
GNN & GAN |
ADNI |
rs-fMRI |
AD-related patterns extraction |
(Pan et al., 2021b)
|
Feature-consistent GAN |
ADNI |
MRI, PET |
Joint synthesis and diagnosis |
(Lin et al., 2021) |
Reversible GAN |
ADNI |
MRI, PET |
Bidirectional mapping between modalities |
(Gao et al., 2021) |
Pyramid and Attention GAN |
ADNI |
MRI, PET |
Missing modality imputation |
(Yu et al., 2021) |
Higher-order pooling GAN |
ADNI |
MRI |
Semi-supervised learning |
(Pan et al., 2021a) |
Decoupling GAN |
ADNI |
DTI, rs-fMRI |
Abnormal neural circuits detection |
(Zuo et al., 2021) |
Hypergraph perceptual network |
ADNI |
MRI, DTI, rs-fMRI |
Abnormal brain connections analysis |
Tumor Detection
|
|
|
|
|
(Han et al., 2019) |
PGGAN & MUNIT |
BRATS |
MRI |
Tumor image augmentation |
(Huang et al., 2019) |
Context-aware GAN |
BRATS |
T1, T2, FLAIR |
Glioma severity grading |
(Park et al., 2021) |
StyleGAN |
Private |
T1, T2, FLAIR |
IDH-mutant glioblastomas generation |
Anomaly Detection
|
|
|
|
|
(Wei et al., 2019) |
Sketcher-Refiner GAN |
Private |
PET, DTI |
Myelin content in Multiple Sclerosis |